{"id":205314,"date":"2026-08-17T09:18:41","date_gmt":"2026-08-17T03:48:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=205314"},"modified":"2026-08-17T09:18:41","modified_gmt":"2026-08-17T03:48:41","slug":"why-kwality-pharmaceuticals-ltd-share-price-52-week-high-2026-08-17","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-kwality-pharmaceuticals-ltd-share-price-52-week-high-2026-08-17\/","title":{"rendered":"Kwality Pharmaceuticals Ltd. (KPL): Kwality Pharmaceuticals Share Price Hits Fresh 52-Week High at Rs 3,725.45"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Kwality Pharmaceuticals Share Price rose to Rs 3,725.45, up 8.15% today, marking a fresh 52-week high. The company\u2019s market capitalisation stood at Rs 3,574.34 crore.<\/p>\n<p style=\"margin-top:0!important;\">Kwality Pharmaceuticals Share Price climbed to Rs 3,725.45 on 17 August 2026, up Rs 280.70 or 8.15% from the previous close of Rs 3,444.75, and in the process touched a fresh 52-week high. With the move, the company\u2019s market capitalisation stood at Rs 3,574.34 crore. For traders scanning 52 Week High Stocks and Stocks in News, this places Kwality Pharmaceuticals Ltd. firmly on the early market radar.<\/p>\n<p>Today\u2019s price action is notable because the stock\u2019s day high and its fresh one-year high were the same at Rs 3,725.45, showing that the strongest traded level of the session also marked the yearly high. The supplied data confirms the price event, the size of the move and the turnover, but it does not establish a company-specific catalyst behind the rise.<\/p>\n<p>For investors following Kwality Pharmaceuticals Share Price Today and broader Share Market Today trends, the immediate focus is on three verified areas: the sharp move from the previous close, the stock\u2019s valuation against the Healthcare sector benchmark, and how its profitability ratios compare with peers. Univest analysis also suggests that the stock is drawing attention because the market-cap profile is now larger than the same-sector median and average figures supplied in the benchmark snapshot.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Kwality Pharmaceuticals Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,725.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,444.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 280.7 (+8.15%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,502<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,725.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,501.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,597<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.59 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,574.34 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) traded at Rs 3,725.45. versus the previous close of Rs 3,444.75, a rise of 8.15%. The stock opened at Rs 3,502, reached Rs 3,725.45, touched Rs 3,501.95. Reported volume was 1,597.<\/p>\n<p>Kwality Pharmaceuticals Share Price Today opened at Rs 3,502.00 and moved in a tight but upward intraday band before hitting a fresh 52-week high of Rs 3,725.45. Against the previous close of Rs 3,444.75, the stock gained Rs 280.70, while turnover stood at Rs 0.59 crore and current volume was 1,597 shares.<\/p>\n<p>The day\u2019s trading setup shows that the stock opened above the previous close and maintained strength through the session range. The day low was Rs 3,501.95, almost identical to the opening level of Rs 3,502.00, which indicates that the stock did not meaningfully slip below its initial traded zone before extending higher. The day high of Rs 3,725.45 was also the 52-week peak, confirming that the stock set a new yearly high during live trading.<\/p>\n<p>In percentage terms, the jump of 8.15% is substantial for a single session move. For market participants tracking Kwality Pharmaceuticals Share Price Live, the data points to strong early price expansion rather than a marginal new high. Turnover of Rs 0.59 crore and volume of 1,597 shares show that the breakout to the one-year high came on measurable activity, even though the supplied dataset does not provide a longer average-volume comparison.<\/p>\n<p>As Univest tracks this Kwality Pharmaceuticals Share Price Update, the key takeaway from price action alone is straightforward: the stock moved higher from open, stayed above the prior close, and printed a fresh 52-week peak. That naturally shifts attention from pure price action to whether the underlying valuation and profitability metrics support continued investor attention.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_Ltd_KPL_Fundamental_Analysis\"><\/span><strong>Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,574.34 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">184.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. was valued at a P\/E ratio of 184.72x, a P\/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">184.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,603.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.71%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.15%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,574.34 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 135.27 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) is classified under sector: Healthcare.<\/p>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a P\/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. Kwality Pharmaceuticals Ltd. (KPL) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,985.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">184.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,827.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">68.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,645.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,612.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\"><strong>Fredun Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FREDUN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,559.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">58.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.15<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a P\/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Kwality Pharmaceuticals Ltd. (KPL) has a market capitalisation of Rs 3,574.34 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Kwality_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Kwality Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kwality Pharmaceuticals Share Price is attracting attention because the verified data combines a strong price event with unusual valuation and sector positioning. In the context of Stock Market Today and Top Gainers Today screens, these are the main points investors are watching.<\/p>\n<ul>\n<li><strong>Fresh price milestone:<\/strong> the stock hit a new 52-week high of Rs 3,725.45 and closed the gap well above the previous close of Rs 3,444.75 during the session.<\/li>\n<li><strong>Strong daily move:<\/strong> today\u2019s gain was Rs 280.70, or 8.15%, which is meaningful for intraday Share Price News and Stock Updates tracking.<\/li>\n<li><strong>Market-cap scale:<\/strong> market capitalisation at Rs 3,574.34 crore is above both the Healthcare benchmark median and average.<\/li>\n<li><strong>Valuation divergence:<\/strong> P\/E of 184.72 is above sector norms, while P\/B of 0.45 is below them.<\/li>\n<li><strong>Return ratios:<\/strong> ROE of -2.89 and ROCE of -0.26 remain below sector benchmark levels, keeping the financial picture mixed.<\/li>\n<li><strong>Peer positioning:<\/strong> the stock is larger in market cap than the supplied peer basket, but profitability compares less favourably with several peers.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Kwality_Pharmaceuticals\"><\/span><strong>About Kwality Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kwality Pharmaceuticals Ltd. (KPL) is a listed Indian company tracked on the exchanges under the symbol KPL. In the supplied dataset, the company is classified within the Healthcare sector, which provides the main basis for sector and peer comparison in this article.<\/p>\n<p>From a market perspective, the company is currently being evaluated alongside other Healthcare names in a 201-company same-sector benchmark and against a smaller listed peer set that includes pharmaceutical and healthcare businesses. That context matters because current investor attention is being driven less by a broad company profile disclosure in the supplied data and more by measurable stock-market signals such as the fresh 52-week high, market capitalisation, valuation multiples and return ratios.<\/p>\n<p>For readers tracking Kwality Pharmaceuticals Company News, Kwality Pharmaceuticals Latest News and Kwality Pharmaceuticals Share News, the most verified current context is that the company has entered the spotlight through a fresh yearly high within the Healthcare pack. Univest will typically view such moves through price action, valuation, sector placement and peer comparison rather than through unsupported assumptions.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Kwality_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Kwality Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\">Kwality Pharmaceuticals Ltd. (KPL) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors following Kwality Pharmaceuticals Share Price can track live share price moves, 52-week levels, market-cap changes, valuation ratios, peer positioning and broader market insights on Univest. The platform helps users monitor Kwality Pharmaceuticals Share Price Today alongside sector context, stock performance and verified data points that matter during event-led sessions.<\/p>\n<p>For users researching Kwality Pharmaceuticals NSE and Kwality Pharmaceuticals BSE trends, Univest brings together Share Price Live tracking, fundamental ratios, sector comparisons and market updates in one place. That can help investors follow how a fresh 52 Week High develops over time without relying on speculation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Kwality_Pharmaceuticals_Share_Price_Today\"><\/span><strong>What is the latest Kwality Pharmaceuticals Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals Share Price Today was Rs 3,725.45 in the supplied market snapshot. The stock was up Rs 280.70 or 8.15% from the previous close of Rs 3,444.75, making it one of the notable stocks in news.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Kwality_Pharmaceuticals_hit_a_fresh_52-week_high_today\"><\/span><strong>Did Kwality Pharmaceuticals hit a fresh 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, the stock touched a fresh 52-week high of Rs 3,725.45. That was also the day\u2019s high, which means the strongest traded price of the session coincided exactly with the new one-year high level.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Kwality_Pharmaceuticals_Share_Price_rising_today\"><\/span><strong>Why is Kwality Pharmaceuticals Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Kwality Pharmaceuticals Share Price rose 8.15% and hit a fresh 52-week high. It verifies the market move, turnover and valuation context, but it does not establish a company-specific catalyst behind today\u2019s rise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_opening_high_and_low_levels_for_the_stock\"><\/span><strong>What were the opening, high and low levels for the stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock opened at Rs 3,502.00, touched a high of Rs 3,725.45 and recorded a low of Rs 3,501.95. This shows the session\u2019s low stayed near the opening level before the price extended higher.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>What is the market capitalisation of Kwality Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s market capitalisation stood at Rs 3,574.34 crore in the supplied data. That figure is above the Healthcare sector benchmark median of Rs 135.27 crore and the benchmark average of Rs 456.49 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Kwality_Pharmaceuticals_valued_on_PE_and_PB\"><\/span><strong>How is Kwality Pharmaceuticals valued on P\/E and P\/B?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals was trading at a P\/E ratio of 184.72 and a P\/B ratio of 0.45. Its P\/E is above the Healthcare sector median of 21.1, while its P\/B is below the sector median of 1.9.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_ROE_and_ROCE_figures_show\"><\/span><strong>What do the ROE and ROCE figures show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied profitability snapshot shows ROE at -2.89 and ROCE at -0.26. Both figures are below the Healthcare benchmark medians of 10.71 for ROE and 13.15 for ROCE, indicating weaker return ratios versus the sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Kwality_Pharmaceuticals_compare_with_its_supplied_peers\"><\/span><strong>How does Kwality Pharmaceuticals compare with its supplied peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals has a market cap of Rs 3,574.34 crore, higher than the supplied peer set. However, its P\/E of 184.72 is above most peers, while ROE and ROCE compare less favourably against several companies listed alongside it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_does_Kwality_Pharmaceuticals_belong_to\"><\/span><strong>Which sector does Kwality Pharmaceuticals belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals Ltd. is classified in the Healthcare sector in the supplied dataset. The sector benchmark used for comparison covers 201 companies, giving context to the stock\u2019s current valuation, market capitalisation and return ratios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_after_this_fresh_52-week_high\"><\/span><strong>What should investors monitor after this fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can monitor whether Kwality Pharmaceuticals Share Price holds near the fresh 52-week peak, how valuation metrics compare with peers, and whether future financial performance improves from the current ROE of -2.89 and ROCE of -0.26.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kwality Pharmaceuticals Ltd. Share Price hits a new 52-week high at Rs 3,725.45. marking a 8.15% rise today. Market cap stands at Rs 3,574.34 crore.<\/p>\n","protected":false},"author":29,"featured_media":205313,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-205314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["205313"],"rank_math_title":["Kwality Pharmaceuticals Share Price at Fresh 52-Week High"],"rank_math_description":["Kwality Pharmaceuticals Share Price hit a fresh 52-week high at Rs 3,725.45. Track price action, valuation, peer comparison and sector analysis."],"rank_math_focus_keyword":["Kwality Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Kwality_Pharmaceuticals_Ltd_KPL_Kwality_Pharmaceuticals_Share_Price_Hits_Fresh_52_Week_High_at_Rs_372545_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/205314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=205314"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/205314\/revisions"}],"predecessor-version":[{"id":205315,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/205314\/revisions\/205315"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/205313"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=205314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=205314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=205314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}